News About: Pharm. Industry
Korean competitors challenge Pfizer's leadership in amlodipine
Korea's major pharmaceutical firms are racing to increase their market share in the domestic amlodipine market, prompting speculation that Pfizer Korea, a Korean unit of a multinational pharmaceutical firm, may face a...
Government funding may encourage local R&D projects, KPMA says
The Korean government's substantial R&D investment will enable local pharmaceutical firms to spur their R&D new drug projects in the years ahead, said an official from the Korea Pharmaceutical Manufacturers Associatio...
Korea Kolma to enter pharmaceutical business.
Korea Kolma declared a pharmaceutical business entry with their long accumulated technologies in the areas of the cosmetic raw material development and its finished product manufacture.
President Yoon Dong-han of ...
Foreign vaccine firm faces administrative disposition for false advertisements
Amid growing controversy over the efficacy of imported influenza vaccine, the Korea Food and Drug Administration said on October 27 that it is considering taking administrative measures to GlaxoSmithKline (GSK) for fa...
Yuhan and Choongwe assessed as high growing potentiality.
According to Hanyang security company's analysis Yuhan sales for the first 3 quarters grew up by 10.1% from the previous year term at 250,550 million won which reflected about 7,300 million won of loss accrued from th...
Intensive subsidy necessary on growth potential products.
Dr. Han Byeong-hyeon of the Korea Health Industry Development Institute (KHIDI) recently reported in his paper titled "The present status and its development plans for pharmaceutical industry" that the intensive suppo...
GSK holds launching ceremony for UltivaGSK said its launching ceremony for Ultiva (remifentanil hydrochloride), a new analgesic opioid agent, was held on October 23 at Grand Hyatt Hotel, where 300 local anesthetists ...
|
Handok Pharm seeking to renew relationship with wholesalers
Handok Pharm wants to re-establish the existing relations with domestic drug wholesalers nationwide through its proposed three-day-long meeting beginning November 11, a company official said.
The move came after wh...
Fluarix using different strains from those of other vaccines, GSK says
GlaxoSmithKline said recently that its Fluarix, an influenza vaccine, is using different strains from those of other vaccines, in response to the controversial announcement of the Korea Food and Drug Administration an...
Choong-wae's itraconazole wins COS certification
Choong-wae said on October 24 that its itraconazole has acquired a COS (Certification of Suitability of Monographs of the European Pharmacopoeia) certification from the European Directorate for the Quality Medicines, ...
